Abstract:A 60-year-old right-handed woman presented with two weeks of gradual onset, progressive holocephalic headache. Three days after headache onset she developed horizontal diplopia, fever, new-onset hypertension, and a fine action tremor of both hands. The diplopia was not present on closing either eye. Examination was normal including inspection of ocular motility, however the diplopia worsened on left gaze and right head tilt. All her symptoms resolved in four days except for fever, which lasted two more days. Routine serum tests were normal and her sedimentation rate was 23. Magnetic resonance imaging (MRI) was normal except for a six-millimeter cyst lateral to the right basal ganglia and a three millimeter T2 hyperintensity in the right parietal white matter. The cerebrospinal fluid protein was 45 mg/dl, glucose was 65 mg/dl, there were nine red blood cells, and 72 white blood cells, of which 35% were neutrophils and 65% were mononuclear cells. Cultures were negative. Serum testing for the West Nile Virus (WNV) was positive for both IgM and IgG. Knowledge of the neurological manifestations of WNV infection is evolving as clinical experience accumulates. Sejvar et al detailed several different syndromes following WNV infection such as encephalitis, meningitis, poliomyelitis-like acute flaccid paralysis, tremor, myoclonus, and Parkinsonism.1 There have been a few reports of cranial nerve involvement during infection. Miller and Liang have reported a patient with fever, headache, and diplopia that had positive WNV laboratory testing.2 Johnston and Chan reported a patient with acute flaccid paralysis who developed bilateral facial weakness and was positive for the WNV.3 Pepperell et al reported the results of 64 patients with WNV infection of whom the three principal types of neurological manifestations were decreased level of consciousness, brainstem and cerebellar signs, and neuromuscular weakness; they list eight patients with “diplopia or opthalmoplegia”.4 Several other cases have been described with ocular motor palsies in association with active WNS infection.5,6 Sampson and Armbrustmacher reported the autopsy results of four patients with WNV, two of who had endoneural mononuclear cell inflammation in the cranial nerve roots.7 This case adds evidence that infection with the WNV can present clinically with disturbance of ocular motility causing diplopia.

Synthesis of Dehydroabietic Acid-Modified Chitosan and Its Drug Release Behavior

Synthesis, characterization and antifungal properties of dehydroabietic acid modified chitosan

Biodegradable Hyaluronic Acid/n-Carboxyethyl Chitosan/protein Ternary Complexes As Implantable Carriers for Controlled Protein Release.

Evaluation of chitosan-ferulic acid microcapsules for sustained drug delivery: Synthesis, characterizations, and release kinetics in vitro

Synthesis and characterization of poly (acrylamide‐co‐acrylic acid)/chitosan (derived from fish scales) for controlled release of amoxicillin drug

Preparation and characterization of N-phthaloyl-chitosan-g-(PEO–PLA–PEO) as a potential drug carrier

Synthesis of Gallic Acid-Loaded Chitosan-Grafted-2-Acrylamido-2-Methylpropane Sulfonic Acid Hydrogels for Oral Controlled Drug Delivery: In Vitro Biodegradation, Antioxidant, and Antibacterial Effects

Preparation of modified chitosan - Amino acid nanoparticles

Synthesis of Chitosan/Diatomite Composite as an Advanced Delivery System for Ibuprofen Drug; Equilibrium Studies and the Release Profile

Synthesis of Chitosan-Modified Diclofenac Acid Prodrug Nanoparticles and Evaluation of Their Anti-Inflammatory Effects in a Preclinical Model

DEAE/Catechol-Chitosan Conjugates as Bioactive Polymers: Synthesis, Characterization, and Potential Applications

Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium

Citric acid crosslinked chitosan/poly(ethylene oxide) composite nanofibers fabricated by electrospinning and thermal treatment for controlled drug release

Synthesis of Β-Cyclodextrin Modified Chitosan–poly(acrylic Acid) Nanoparticles and Use As Drug Carriers

Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems

Preparation and Characterization of Chitosan/LDH Composite Membranes for Drug Delivery Application

An Amphiphilic Chitosan Derivative Modified by Deoxycholic Acid: Preparation, Physicochemical Characterization, and Application

Chitosan hydrogels chemically crosslinked with L-glutamic acid and their potential use in drug delivery

Modification of Hydroxypropyltrimethyl Ammonium Chitosan with Organic Acid: Synthesis, Characterization, and Antioxidant Activity

Diplopia Secondary to West Nile Virus Meningitis.

Chitosan and Hydroxy Propyl Methyl Cellulose as a Carrier for Aceclofenac for Prolonged Release